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Silicone use in Nepali transgender women: The hazards of beauty 
Abstract 
Purpose: It is widely believed that transgender individuals in Nepal inject silicone for face 
and body manipulation, a phenomenon thought to be common among transgender individuals 
globally.  Therefore, this qualitative study conducted in Nepal explored: a) awareness of 
silicone use and sources of information; b) reasons for using silicone; c) notion of cost and 
quality of these procedures; d) reported negative aspects, including side effects; and, e) health 
seeking behaviours of Nepali transgender women. Design/methodology/approach: We 
carried out eight focus group discussions (FGDs) with transgender women at four different 
districts of Nepal, five in the capital Kathmandu and three in different rural areas. We also 
interviewed three transgender women who preferred not to participate in the FGD but were 
happy to be interviewed separately. Similarly, six interviews with stakeholders working for 
sexual and gender minority populations were also conducted. Findings: Most FGD 
participants were young (mean age 23.06±3.9 years) and the majority (55%; n=34) completed 
grade six to high school level. Peer networks of transgender people and the internet were the 
more popular sources of information about silicone. The decision to use silicone was largely 
influenced by the desire to look beautiful and more feminine. Often they appear not to follow 
the recommended procedures for silicone use. Their health seeking behaviour regarding side 
effects or complications of these procedures was very poor. Originality/value: Findings 
reflect that targeted interventions aimed at transgender individuals should educate them on 
the use of silicone, as well as explore safe and affordable approaches to meet gender-related 
appearance needs of Nepali transgender people.  
Key words: Silicone injection, transgender, harm reduction, South Asia 
Introduction 
Injecting silicone to manipulate physical appearance is thought to be common among 
transgender women, mainly applied to lips, thighs, breasts, hips and buttocks to achieve a 
cosmetic enhancement. Silicone is easy to inject, permanent, and relatively inexpensive [1]. 
However, for many transgender women, accessing illicit silicone fillers may be the only 
choice available to make changes to their appearance due the high costs of gender affirmation 
surgeries [2]. As this substance is not approved for body modification or cosmetic purposes 
[3], transgender people may inject silicone without a medical supervision. Studies have 
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shown the use of silicone by the transgender people ranging from 17% in San Francisco, 
USA, 49% in Brazil [4] to a high of 69% in a transgender sample in Thailand [5].  
Injecting silicone frequently involves non-medical products and equipment in 
nonsterile and non-health environments [6]. Mass media often report about injecting low 
grade substances to attain a feminine shape. For example, a transgender women referred to in 
the media as a “toxic tush doctor”, was sentenced for injecting a mixture of cement, glue, 
mineral oil and tire sealant into a woman’s buttocks [7]. Past research and case reports have 
reported the hazards of silicone injections such as infection, foreign body reaction 
(hypersensitivity), granulomatous diseases, unavoidable dermatologic complications and 
migration of the silicone/implantable material [1, 6, 8-11]. These complications may require 
transgender women to attend a dermatologist or plastic surgeon. In some cases, silicone 
injection has led to acute pulmonary haemorrhage, pneumonitis and organ injury or failure 
[6]. This suggests that the use of non-medical grade products, incorrect volumes and/or 
placement can have life threatening health consequences for transgender people. 
Over the past decades, Nepal has witnessed significant legal improvements that affirm 
rights of sexual and gender minority (SGM) people such as lesbian, gay, bisexual and 
transgender (LGB&T). The Constitution of Nepal and strategic documents such as the Nepal 
Health Policy [12] and the Nepal Health Sector Strategy 2015-2020 [13] protect the rights of 
SGMs [12, 13]. Nepal currently acknowledges its transgender community by allowing a third 
category of ‘others’ [meaning ‘other sex’ than male or female] on passports, citizenship 
certificates, voters’ identity card and immigration forms. However, this socially vulnerable 
population faces high levels of discrimination in social, administrative and health care 
settings in a culture that is often very traditional. This results in high levels of unmet needs in 
health and social care among transgender populations.  
There are about 25 million trans people worldwide [14]. In Nepal, it is estimated for 
2016 that the range of transgender individuals is between 18,704 and 24,216, without 
specifying the proportion of trans women or men [15]. However, the ambiguity around 
definitions of transgender identity combined with stigma and discrimination of transgender 
populations makes it hard to establish precise numbers of the transgender population. The 
recent proposal to shift descriptive elements of transgender identity from ‘mental health 
disorders’ to ‘sexual health categories’ may reduce stigma and help improve the estimation of 
the size of this population [16]. 
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Recent global literature signals that the general health of transgender people is among 
the least prioritised research fields [17, 18]. Limited research on transgender individuals in 
Nepal or other South Asian countries suggests that these studies are predominantly focused 
on human immunodeficiency virus (HIV), sexually transmitted infections (STIs), sexual 
behaviour and, recently, around mental health and well-being issues of the transgender 
population. It could be due to the fact that transgender population is one of the key 
populations that are disproportionately affected by HIV [19]. For example, transgender 
individuals in low and middle-income counties (LMICs) are 50 times more likely to be 
infected with HIV than other adults of reproductive age [20]. The high prevalence of HIV 
among Nepali transgender [e.g., men having sex with men (MSM): 6% vs. transgender: 
11.5%] is also documented in the recent Integrated Biological and Behavioural Survey 
(IBBS) of Nepal [21]. Similarly, compared to MSM, a higher proportion of transgender 
people in Nepal experience suicidal ideation (39.8% vs. 21.3%) and attempt suicide (15.3% 
vs. 6.4%) [22]. Smoking and alcohol consumption are also widespread in Nepal’s transgender 
people [23]. Uptake of health care services including HIV Testing and Counselling (HTC) by 
Nepal’s  transgender population is also poor [24]. Since Nepali societies are generally 
conservative and condemn sexual orientation other than heterosexuality, it can be difficult for 
trans people to seek health and social care services [25]. 
Similar to transgender people from other geographical settings, it is believed that 
transgender women in Nepal also use silicone for face and body manipulation. However, 
there is a lack of research on silicone use by Nepali transgender. In this paper, we report 
findings from a qualitative study that primarily aimed to explore hormone use by Nepali 
transgender women [26]. During focus groups discussions (FGD) [27] and interviews [28] 
with transgender women, many unexpectedly spoke about issues around silicone use. 
Therefore this paper focuses on such issues raised by participants around silicone use.   
Methods and materials  
We conducted eight FGDs among transgender women aged 18 years and above. The number 
of participants in each FGD ranged between seven to nine persons. In order to capture diverse 
views, eight FGDs (five in capital city of Nepal, Kathmandu) were carried out in four of the 
seven provinces of Nepal (Table 1), representing mountain, hill and terai (low land region of 
Southern Nepal). As in most countries of the world marginalised groups often are attracted to 
the bigger cities because attitudes there are generally more liberal. Nepal has a largely rural 
population with only one real big city. We included three transgender women who preferred 
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not to participate in the FGD but liked to be interviewed separately. Similarly, we carried out 
six key informant interviews (KII) with relevant stakeholders, including representatives 
working in Non-Governmental Organisations (NGOs) supporting the SGM population in 
Nepal. We conducted FGD and interviews up to the data saturation point [29]. 
Table 1: FGD participants by study areas 
Province/district   Participants N  
Province 1: Sunsari (1 x FGD) 8 
Province 3: Kathmandu (5 x FGD) 39 
Province 4: Kaski (1 x FGD) 7 
Province 6: Banke (1 x FGD) 8 
Total 62  
 
We invited potential research participants using a convenience sampling strategy in 
close collaboration with a non-governmental organisation (NGO) working for the SGM 
population in Nepal. Participants for the FGDs were invited through the NGO’s network as it 
was not possible to use more public recruitment strategies for this hard-to-reach and 
marginalised population.  
The FGDs and interview guides were developed based on the literature and expert 
consultation, and pretested [30] through one FGD with transgender women in Kathmandu. 
Copies of FGD and interviews schedules are available from the first author on request. All 
the FGDs and interviews were conducted in Nepali by experienced qualitative researchers in 
a private place which was mutually agreed by the researchers and the participants. Most of 
our FGDs lasted between one to two hours whereas interviews took between 45 minutes to 
one hour. The researchers made short field notes of non-verbal behaviour during the 
qualitative data collection. 
With permission from the participants, the FGDs and interviews were audio recorded. 
These recordings were transcribed [31] and then translated into English by a Nepali 
researcher. Transcripts were crossed checked with original recordings. Any transcription 
disagreements were discussed between the PRR and SRN. Each transcript listed the setting, 
how the discussion had established, key differences to previous qualitative data and a 
reflection on issues identified in the session. NVivo 11 (QSR international Pty Ltd, Australia) 
was used to organise qualitative data [32]. As part of the thematic analysis [33], PRR 
inductively coded all transcripts (interviews and FGDs together) and EvT and SRN coded 
half of the transcripts each as second independent coders. All data concerning silicone use 
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contributed to the distillation of the themes listed below. Relevant quotes are presented to 
illustrate the key themes [34]. A consolidated criteria for reporting qualitative studies 
(COREQ) checklist was followed to report the qualitative data from this study [35]. 
Our study protocol was approved by Bournemouth University [Ref: 12251] and the 
Nepal Health Research Council [Ref: 188/2016]. Through a participant information sheet in 
Nepali, research participants were provided with information about the study procedure, 
confidentiality, study purpose, risk and benefits to the participants and complaint procedure 
[36]. Informed consent was obtained from all research participants prior to FGDs and 
interviews. No monetary incentive except travel expenses were offered to participants.  
Results 
The mean age of FGD participants was 23.06±3.9 years and more than half of the participants 
(55%) had completed grade six to high school level. Just under one-third of our FGD 
participants had completed higher secondary education (above School Leaving Certificate 
[SLC] level). Most participants (n=51; 82%) were from Brahmin/Chhetri and Janajati 
ethnicity, some 39% lived with friends and 42% worked in restaurant/bars.  
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Table 2: Characteristics of FGD participants 
Socio-demographic Characteristics (N=62)  N (%) 
  
Ethnicity*  
Brahmin/Chhetri 26 (41.9) 
Newar  8 (12.9) 
Janajati (including Tharu/Chanduari) 25 (40.3) 
Dalit  3 (4.8) 
Education   
Up to primary (up to 5 grade)  9 (14.5) 
Up to school level (6 to SLC) 34(54.8) 
Higher (above SLC) 19(30.6) 
Occupation  
Bar dancer 12(19.4) 
Waiter 14(22.6) 
Business  4 (6.5) 
NGO/development  worker 4 (6.5) 
Sex worker 3(4.8) 
Modelling/fashion 1(1.6) 
Unemployed 24 (38.7) 
Currently living with  
Friends 24 (38.7) 
Family 24 (38.7) 
Alone 14 (22.6) 
Time at current address  
<6 months 15 (24.2) 
>6 months 47 (75.8) 
*Ethnicity recoded as per the Census of Nepal  
 
Five themes emerged from the FGD and interviews: (a) familiarity and source of information 
about silicone; (b) reasons for silicone use; (c) notions of cost and quality; (d) reported 
negative aspects; and (e) health-seeking behaviours of Nepali transgender women. These are 
discussed in turn below.  
a) Familiarity and source of information about silicone 
Most participants were familiar with silicone use among Nepali transgender people. When 
asked they noted the internet, particularly ‘YouTube’ or ‘Google’ and peers as the main 
sources of information, for example: 
“…It is a generation of internet. We can know everything if we search in Google. For 
this, we should know to check in internet.” (FGD, VII) 
 “…I watch YouTube and learn about many things including silicone use, sex change 
surgery... we also learn many things from our friends who have done these things…I 
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found out from my friend who works with me in the same office. I went with him for 
silicone injection as he knew the place.” (FGD VIII) 
Participants stated that services for injecting silicones are not widely available in Nepal but 
they claimed that there are many places in Kathmandu where these procedures are carried 
out. Many participants spoke about having used silicone, as exemplified by the following 
quotes: 
“Here are fillers [silicone] for my beautiful chin. This is not Botox, it is silicon.” 
(FGD, I) 
“I have injected silicone. She has also done [pointing to another participant]. It is 
available in Kathmandu.” (FGD, I) 
b) Reasons for silicone use  
Our participants highlighted several factors that encourage them to use silicone. Frequently 
reported reasons were their body image, identity and wider social acceptancy. Some also 
argued that personal satisfaction, opportunity for long-term relationships (e.g., marriage) 
were the other reasons for injecting silicone by transgender women. One participant stated: 
“I used to feel a bit uncomfortable previously. I did not use to roam here and there 
but was running my own hotel. Boys used to come, eat at my hotel but also wanted to 
touch here [=showing breast]. They would say that this person is like this…so I did 
this [silicone injection]. Now I feel better than before.” (FGD, III) 
Another participant spoke about silicone use to help her look more feminine without going 
through a sex change operation: 
“I am transgender and want to maintain my identity. I think about implanting silicone 
if I get the money but I do not want to undergo the complete sex change and become a 
woman. Some of our friends do want to have sex change but I don't have that desire.” 
(FGD, IV) 
“When we ask them if they are using any medicine to become like a girl then most of 
them say, “Everything is fine. I just want to increase my breast by using pills or 
silicone.” (KII, III) 
Similarly, financial benefits to look more feminine, particularly by transgender sex workers 
are also frequently shared by participants, for example:  
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“…Some work as sex worker so they need to look beautiful to attract clients. Lower 
part [of your body] can be covered, and can only be shown during that time [=sex] 
but more attraction is focused on the upper part [=breasts]. So it is compulsory to 
have[=silicone implant]. If their upper part [breasts] looks natural then they can get 
the amount they want.” (In-depth Interview, III) 
“Rather than earning, actually we do not want to do sex work. It is easier for us to 
negotiate for extra money if our body looks nice.” (FGD, III) 
The notion of fewer side-effects of silicone compared to other procedures for body 
manipulation such as sex hormones or sex reassignment surgery was also reported, as 
exemplified by these quotes:   
“…hormone use produces adverse effects to our health…compared to that silicone 
use do not cause any sort of major complications so we want to take this but it is not 
cheap either.” (FGD, IV) 
Others suggested silicone might be used after hormone therapy or in combination with it:  
“My friend used silicone because her breast did not develop.” (FGD, II) 
c) Notions of cost and quality 
There was a consensus among participants that the quality of services abroad is much better 
than in Nepal, therefore, they always preferred getting silicone abroad, particularly in 
Bangkok: 
“…Yes, it is done in Teku [a place in Kathmandu]…we have seen our friends get 
silicone there…There is some difference like in case of Bangkok they do it [=silicone 
implant] from armpit but here [=Nepal] they do from here [=showing side of the 
breast]. Stitches are also visible if it is done from here [=showing side of breast] 
while it would not be so visible in the armpits.” (FGD, VII) 
“…I have heard that silicon implantation is available in Nepal these days. But I 
haven’t done silicone implant in Nepal. I went abroad for this.” (In-depth Interview, 
III) 
“…one done in Nepal is a bit hard…it is not as good as in Thailand.  The wound may 
be visible if you do in Nepal.” (FGD, II) 
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Participants shared that the cost for of silicone implants ranged from one to two hundred 
thousand Nepali Rupees (equivalent to USD 1,000 to 2,000) but it really depends on the 
amount of silicone inserted. If injecting silicone is performed overseas, the travel and 
accommodation add extra costs as reported by participants: 
“…I have used silicon here [=breasts]. It costed me about two lakhs [=USD 2000] 
and something to go and to return [Thailand]. It costed one lakh fifty thousand 
[=USD 1500] for silicon implant only.” (FGD, VII) 
These high cost associated with the procedures were highlighted as barriers to seeking these 
services. Hence, some participants mentioned that only wealthy people can afford these 
procedures, for example:  
“…only people who has good job can afford these procedures. Some are in modelling 
field and some are running their own business…they may go overseas and take 
services.” (FGD, III) 
“…I am saving money for making the upper part first [silicone use in breast]. I will 
possibly do sex change later.” (FGD, II) 
One interviewee opted for hormones as these are cheaper than silicones:  
 “I took Nilocon White [=oral contraceptive pill] as I did not have enough money for 
silicone use.” (In-depth Interview, II)  
d) Negative aspects  
Though many argued that there are few side effects of silicone use, some reported negative 
aspects of these procedures. They agreed that silicone needs to be carefully handled, 
especially massaged:  
“…It has a chance of getting damaged. In some people, it might be hard if massage is 
done carelessly during the “medicine period” immediately after insertion. In many 
people, it becomes loose and reaches till here because of excess massage. Getting 
loose is also fault and becoming hard like stone is also fault.” (FGD, I) 
There was also the view that the weather can impact adversely on silicone implants: 
“…Silicon implant of [name] had already hanged down. Also, the climate of 
Nepalgunj [western Nepal] is not good, it is very hot there. And the weather of 
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Kathmandu is also not good. If we have any problem then how can we come to 
Kathmandu and how can we go overseas?” (KII, V) 
Another key informant said: 
“…They get information from their friends so they have not clearly understood about 
the side effects and future consequences of these procedures. If they use this without 
counselling, they might not have any instant side effect now but they there be huge 
side effects in the future. So, there is a need of counselling for them.” (KII, IV) 
e) Health-seeking behaviour 
Participants generally believed that there is no need for follow up care after silicone use. 
They claimed that health care seeking or counselling after silicone injection is not necessary. 
However, some stated that they would seek health care services if they have any health issues 
related to silicone or hormone use or other health issues. Participants said that they generally 
seek services in Nepal; however, if there is a complicated situation, they prefer to go 
overseas.  
“…[Name] used silicone some time ago. She is going to Bangkok because her breast 
at one side is small and another side is larger.” (FGD, III) 
“Simple follow up is possible here but we have to go abroad [Thailand] only if we 
have any kind of reaction.” (FGD, II) 
“…No, we did not have to do anything [after silicone] like that.” (In-depth Interview, 
I)  
Most said that follow-up services (if required) they get from Nepal are good. Few 
participants, however, said that they may not get proper advice from health care providers in 
Nepal as doctors or nurses may not be aware that transgender people may use silicones.  
Issues of stigma and discrimination were often mentioned related to their transgender 
identity, for example when seeking hospital care: 
“No, I did not go anywhere. If I do check-up and if they show serious problem then… 
I had gone to teaching once. I had to open clothes for video x-ray. There were boys 
also. I felt very shy thinking that breast will be seen.” (FGD, III) 
The following quote gives examples of how interviewees had been ill-treated by health care 
staff who could not accepted their gender identity: 
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“I was very insulted in [=hospital name] counter. It was 7-8 years ago. My hair was 
also long, I used to do make up. I had a bit of a problem and come for check-up. At 
the counter they saw me and insulted me. Then I felt angry and shouted and said, 
“They called me hijada [local term in South Asia for transgender individuals].” (FGD 
III) 
The above quotes illustrate that there is still discrimination in many health services towards 
transgender people in Nepal. This prevents many of them from taking up services or sharing 
their health problems with professionals. 
Discussion  
This is the first study to explore views around silicone use by Nepali transgender women. Our 
study reports that transgender women are aware of silicone use and many have undergone 
procedures to feminize their contours. Peers of transgender people and the internet played a 
significant role in accessing information about silicone use. Indeed, seeking sensitive 
information on topics such as such as sexuality and reproductive health from peers is not 
unique in Nepal [37] or South Asia [38]. However, seeking information from peers may not 
always be a reliable approach due to their poor competency in complex and technical issues. 
Similarly, the internet seems to be a popular channel for information on silicone implants 
among Nepali transgender individuals. We argue that assessing the reliability of online 
information is difficult. Moreover, users require a good level of health literacy as well as 
English language competency as online content is generally in English, suggesting limited 
access to potentially poor information through peer or internet may lead to a ‘badly’ informed 
choice for transgender individuals. 
Participants discussed many factors that encourage them to use silicone. However, 
their main motives are to look more feminine and beautiful. Some even practiced silicone to 
attract clients (those working as sex worker) or establish a long-term relationship. This desire 
may mean they are not always following the recommended procedures for silicone use, 
follow-up or treatment for any side effects. Improper silicone injection practices may lead to 
complications including migration of the silicone [9, 39]. Furthermore, as silicone is a 
permanent material, treatment of its side effects or complications may be difficult. In many 
cases, the only option is surgical excision [1] which can be costly for transgender women 
who are already burden by poor financial circumstances. Lack of access to appropriate care is 
associated with poor mental health outcomes such as depression and non-suicidal and self-
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harm, and suicide among transgender individuals [40, 41].There are also evidence that 
transgender people share needles and syringes to inject hormones or silicone [42]. If 
injections are not performed in a sterile manner or the injection equipment is contaminated, 
there is the additional hazard of the transmission of blood born inflections such as HIV, 
Hepatitis B and C [43]. Targeted interventions to Nepali transgender individual, therefore, 
should help disseminate such information.  
Our participants frequently questioned around the quality of the silicone or the 
procedure available in Nepal. These perceptions force them to seek services abroad which are 
expensive for most transgender individuals as most of them are unemployed or engaged in 
low-income jobs. Moreover, due to the language barriers abroad or poor assertiveness skills, 
transgender people may not know whether they are serviced by medical or non-medical 
practitioners. Many believed that the health professionals in Nepal may not be aware of 
silicone use by the transgender population, which may stop them from seeking care. There is 
need to orient/educate health professionals as they may not understand the need of 
transgender people, or be aware of the health implication of silicone. 
The transgender population will have many health issues on top of sexual and 
reproductive health (SRH) and HIV prevention. The deeply rooted traditional societies have 
not only made the transgender people’s life difficult, this discrimination also acted as a 
barrier to seeking health and social care services. The solve this requires a holistic approach 
to meet the health care needs of transgender people in Nepal. Most current programmes for 
transgender population or other sexual and gender minority population in Nepal are focused 
in promoting safe sex behaviour as they are considered as a ‘key population’ for the HIV 
response due to their high-risk sexual behaviours [19, 20, 23]. Current programmes in Nepal 
ignore silicone use or other procedure such as gender reassignment surgery or hormone use 
among transgender population. If the current interventions provide training on silicone use 
and issues such as hormone use and their side effects, transgender people may cascade the 
proper information to their peers just like they are currently doing for HIV and STI 
prevention and care.  
Although transgender population constitute a small proportion of the population, to 
achieve universal health coverage as envisioned in the Sustainable Development Goals 
(SDG), it is imperative to understand the need of health care and the risk behaviours of the 
transgender population in Nepal. A recommendation for future practice is that programmes 
should explore safe and affordable approaches to meet gender-related appearance needs of 
 13 
 
Nepali transgender people. For future research, we suggest further quantitative research is 
needed to determine: (a) the overall prevalence of silicone use among transgender women; 
and, (b) the consequences of silicone use on the transgender people.  In addition, future 
studies should seek a deeper understanding of factors that motivate transgender people to 
engage in potentially risky behaviours. 
Strengths and limitations 
This is the first in-depth study of its type in Nepal.  Moreover, despite the sensitivity of the 
topic most participants actively engaged during the FGD and interviews, giving us a rich data 
set, and no single participant dropped out during the study. The study also has limitations: 
first, despite having covered the capital and three more remote cities may have missed the 
views of transgender women from other socio-cultural or behavioural backgrounds. 
Secondly, as we recruited through a local organisation working for transgender community, 
we may have missed people who do not want to be part of this network. Thus, our 
participants may be better exposed to the health and social issues facing transgender 
populations. Thirdly, as sexuality issues are not openly discussed in Nepal, our participant 
might not have shared very personal and sensitive issues openly. Finally, as findings of this 
study emerged from a qualitative study that aimed to explore hormone use of Nepali 
transgender women, our focus group and interview questions may have missed other key 
aspects of silicone use. Similarly, as the issue of silicone emerged and was not part of the 
interview schedule many KII did not mention it. If we had asked question to KIIs we may 
have had more responses on the topic from them, as a consequence this paper is largely based 
on insights from transgender women.    
Conclusion 
Nepali transgender individuals are generally familiar with silicone use and other procedures 
such as hormone use, gender reassignment surgery or surgical procedures for body 
manipulation. However, their health-seeking behaviour regarding the hazards in the form of 
side effects or complications is very poor. One practical recommendation is that targeted 
intervention programmes should include education on silicon use and other procedures used 
to manipulate physical appearance and their impacts, including recognising side effects of 
silicone use.  Awareness raising interventions can help transgender populations to make more 
appropriate decisions about both body beautification and health-care seeking if this is 
required.     
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